MIDAZOLAM HYDROCHLORIDE INJECTION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Delivery order SPE2D226F2925 was awarded on July 1, 2026, to DMS Pharmaceutical Group Inc., a Women-Owned Small Business, for the procurement of Midazolam Hydrochloride Injection. This order is issued under the base administrative contract SPE2DX-25-D-9822, which was awarded on March 7, 2025, by the Defense Logistics Agency Troop Support Medical Supply Chain FSB with a total ceiling of 20 million dollars. The specific delivery order consists of two units at a unit price of 8.50 dollars, totaling 17.00 dollars. The items are to be delivered FOB Destination to the USS Anchorage LPD 23 via Fleet Post Office by July 1, 2026. Inspection and acceptance are conducted by the government at the destination. The contract is governed by FAR Part 12 for commercial items, incorporating clauses 52.212-1, 52.212-3, 52.212-4, and 52.212-5. Payment is processed via Fast Pay Net 15 through the Defense Finance and Accounting Service in Columbus, Ohio, with electronic invoicing required per DFARS 252.232-7003. This is a rated order under the Defense Priorities and Allocations System.
General Info
Contract Value
$17Place of Performance
IL, USASet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
